MedPath

Target attainment of ciprofloxacin in patients admitted to a general ward: a prospective observational study

Conditions
Infections treated with ciprofloxacin, according to standard of care
Registration Number
NL-OMON25299
Lead Sponsor
Academic Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Receiving ciprofloxacin therapy intravenous (iv) or per os (po) as part of standard care

-Age ¡Ý 18 years

Exclusion Criteria

-Incapacitated patients, i.e. a minor or legally incompetent adult

-Treatment with ciprofloxacin is started elsewhere

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To investigate whether the current dosing regimen of ciprofloxacin, recommended by the SWAB guidelines and applied at the Academic Medical Center for patients with various degrees of renal function admitted at general wards, results in the target PK/PD index of AUC0-24/MIC &#8805; 125.<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath